Personal Home Page

http://www.fda.gov/nctr/staff/bios-html/sali.html

Articles in Scholarly Journals [Incomplete List]

1. PKU is a reversible neurodegenerative process within the nigrostriatum that begins as early as 4 weeks of age in Pahenu2 mice
   Brain Research, vol. 1127, pp. 136–150, 2007
2. Gene expression profiling of MPP+-treated MN9D cells: A mechanism of toxicity study
   NeuroToxicology, vol. 28, no. 5, pp. 979–987, 2007
3. Drugs of Abuse-Induced Hyperthermia, Blood-Brain Barrier Dysfunction and Neurotoxicity: Neuroprotective Effects of a New Antioxidant Compound H-290/51
   Current Pharmaceutical Design, vol. 13, no. 18, pp. 1903–1923, 2007
4. Serial Analysis of Gene Expression in the Rat Striatum Following Methamphetamine Administration
   Annals of the New York Academy of Sciences, vol. 1074, no. 1, pp. 13–30, 2006
5. Effects of L-Carnitine Pretreatment in Methamphetamine and 3-Nitropropionic Acid-Induced Neurotoxicity
   Annals of the New York Academy of Sciences, vol. 1074, no. 1, pp. 74–83, 2006
6. Methamphetamine, Morphine, and Their Combination: Acute Changes in Striatal Dopaminergic Transmission Evaluated by Microdialysis in Awake Rats
   Annals of the New York Academy of Sciences, vol. 1074, no. 1, pp. 160–173, 2006
7. Alterations in Blood-Brain Barrier Function by Morphine and Methamphetamine
   Annals of the New York Academy of Sciences, vol. 1074, no. 1, pp. 198–224, 2006
8. Methamphetamine Induces Autophagy and Apoptosis in a Mesencephalic Dopaminergic Neuronal Culture Model: Role of Cathepsin-D in Methamphetamine-Induced Apoptotic Cell Death
   Annals of the New York Academy of Sciences, vol. 1074, no. 1, pp. 234–244, 2006
9. Links between Nutrition, Drug Abuse, and the Metabolic Syndrome
   Annals of the New York Academy of Sciences, vol. 1074, no. 1, pp. 303–314, 2006
10. Calpain Activation in Apoptosis of Motoneurons in Cell Culture Models of Experimental Parkinsonism
    Annals of the New York Academy of Sciences, vol. 1074, no. 1, pp. 349–356, 2006
11. Neural Effects of MDMA as Determined by Functional Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy in Awake Marmoset Monkeys
    Annals of the New York Academy of Sciences, vol. 1074, no. 1, pp. 365–376, 2006
12. A Potent Serotonin-Modulating Compound AP-267 Attenuates Morphine Withdrawal-Induced Blood-Brain Barrier Dysfunction in Rats
    Annals of the New York Academy of Sciences, vol. 1074, no. 1, pp. 482–496, 2006
13. The Interaction of Manganese Nanoparticles with PC-12 Cells Induces Dopamine Depletion
    Toxicological Sciences, vol. 92, no. 2, pp. 456–463, 2006
14. Co-regulation of dopamine D1 receptor and uncoupling protein-2 expression in 3-nitropropionic acid-induced neurotoxicity: Neuroprotective role of l-carnitine
    Neuroscience Letters, vol. 410, no. 1, pp. 62–65, 2006
15. The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice
    Pharmacology Biochemistry and Behavior, vol. 83, no. 3, pp. 349–359, 2006
16. Role of nitrergic system in behavioral and neurotoxic effects of amphetamine analogs
    Pharmacology & Therapeutics, vol. 109, no. 1-2, pp. 246–262, 2006
17. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen
    Synapse, vol. 60, no. 3, pp. 185–193, 2006
18. High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus
    Synapse, vol. 60, no. 7, pp. 521–532, 2006
19. Selenium reduces the proapoptotic signaling associated to NF-?B pathway and stimulates glutathione peroxidase activity during excitotoxic damage produced by quinolinate in rat corpus striatum
    Synapse, vol. 58, no. 4, pp. 258–266, 2005
20. Selective Alterations of Transcription Factors in MPP-Induced Neurotoxicity in PC12 Cells
    NeuroToxicology, vol. 26, no. 4, pp. 729–737, 2005
21. Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington’s disease in rats: Protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron (III)
    Neuroscience, vol. 135, no. 2, pp. 463–474, 2005
22. Four weeks of oral isotretinoin treatment causes few signs of general toxicity in male and female Sprague–Dawley rats
    Food and Chemical Toxicology, vol. 43, no. 8, pp. 1289–1296, 2005
23. The differential JunB responses to inhibition of succinate dehydrogenase in rat hippocampus and liver
    Neuroscience Letters, vol. 381, no. 3, pp. 354–357, 2005
24. Nitric oxide mediates increased susceptibility to dopaminergic damage in Nurr1 heterozygous mice
    The FASEB Journal, vol. 19, no. 11, pp. 1441–1450, 2005
25. Differential Effects of Amphetamines-Induced Neurotoxicity on Appetitive and Aversive Pavlovian Conditioning in Mice
    Neuropsychopharmacology, vol. 30, no. 6, Article ID 1300675, 9 pages, 2005
26. A microarray study of MPP+-treated PC12 Cells: Mechanisms of toxicity (MOT) analysis using bioinformatics tools
    BMC Bioinformatics, vol. 6, no. Suppl 2, p. S8, 2005
27. Identification of Rat Hippocampal mRNAs Altered by the Mitochondrial Toxicant, 3-NPA
    Annals of the New York Academy of Sciences, vol. 1053, no. 1, pp. 162–173, 2005
28. Cocaine Induces a Differential Dose-Dependent Alteration in the Expression Profile of Immediate Early Genes, Transcription Factors, and Caspases in PC12 Cells: A Possible Mechanism of Neurotoxic Damage in Cocaine Addiction
    Annals of the New York Academy of Sciences, vol. 1053, no. 1, pp. 482–490, 2005
29. Role of Peroxynitrite in Methamphetamine-Induced Dopaminergic Neurodegeneration and Neuroprotection by Antioxidants and Selective NOS Inhibitors
    Annals of the New York Academy of Sciences, vol. 1053, no. 1, pp. 97–98, 2005
30. Differential Response of nNOS Knockout Mice to MDMA ("Ecstasy")- and Methamphetamine-Induced Psychomotor Sensitization and Neurotoxicity
    Annals of the New York Academy of Sciences, vol. 1025, no. 1, pp. 119–128, 2004
31. Role of Mitochondrial Dysfunction in Neurotoxicity of MPP:+: Partial Protection of PC12 Cells by Acetyl-l-Carnitine
    Annals of the New York Academy of Sciences, vol. 1025, no. 1, pp. 267–273, 2004
32. A Single Exposure to Morphine Induces Long-Lasting Hyporeactivity of Rat Caudate Putamen Dopaminergic Nerve Terminals
    Annals of the New York Academy of Sciences, vol. 1025, no. 1, pp. 414–423, 2004
33. Evaluation of  -Hydroxybutyric Acid for Genotoxicity in the Mouse Micronucleus Assay
    Annals of the New York Academy of Sciences, vol. 1025, no. 1, pp. 538–542, 2004
34. Repeated Exposure to the Abused Inhalant Toluene Alters Levels of Neurotransmitters and Generates Peroxynitrite in Nigrostriatal and Mesolimbic Nuclei in Rat
    Annals of the New York Academy of Sciences, vol. 1025, no. 1, pp. 543–551, 2004
35. Preface
    Annals of the New York Academy of Sciences, vol. 1025, no. 1, pp. xiii–xiii, 2004
36. Long-lasting behavioral sensitization to psychostimulants following p-chloroamphetamine-induced neurotoxicity in mice
    Neuropharmacology, vol. 46, no. 1, pp. 74–84, 2004
37. Neurotoxic effects of MDMA (?ecstasy?) administration to neonatal rats*1
    International Journal of Developmental Neuroscience, vol. 22, no. 5-6, pp. 261–271, 2004
38. Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice
    Brain Research, vol. 1006, no. 2, pp. 150–156, 2004
39. Peroxynitrite decomposition catalyst, iron metalloporphyrin, reduces quinolinate-induced neurotoxicity in rats
    Synapse, vol. 54, no. 4, pp. 233–238, 2004
40. Selective alterations of gene expression in mice induced by MPTP
    Synapse, vol. 55, no. 1, pp. 45–51, 2004
41. Plasma Levels of Parent Compound and Metabolites after Doses of Either d-Fenfluramine or d-3,4-Methylenedioxymethamphetamine (MDMA) that Produce Long-Term Serotonergic Alterations
    NeuroToxicology, vol. 24, no. 3, pp. 379–390, 2003
42. Toluene-Induced Locomotor Activity is Blocked by 6-Hydroxydopamine Lesions of the Nucleus Accumbens and the mGluR2/3 Agonist LY379268
    Neuropsychopharmacology, vol. 28, no. 8, Article ID 1300193, 7 pages, 2003
43. Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies
    Journal of Neurochemistry, vol. 86, no. 2, pp. 479–488, 2003
44. Role of nitric oxide in rotenone-induced nigro-striatal injury
    Journal of Neurochemistry, vol. 86, no. 6, pp. 1338–1345, 2003
45. Acute administration of cocaine regulates the phosphorylation of serine-19, -31 and -40 in tyrosine hydroxylase
    Journal of Neurochemistry, vol. 82, no. 2, pp. 382–388, 2002
46. Peroxynitrite and the regulation of Na+,K+-ATPase activity by angiotensin II in the rat proximal tubule
    Nitric Oxide, vol. 7, no. 1, pp. 30–35, 2002
47. Methamphetamine-induced dopaminergic neurotoxicity in mice Long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine
    Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 26, no. 6, pp. 1177–1183, 2002
48. Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra
    Neuroscience Letters, vol. 329, no. 3, pp. 354–358, 2002
49. Zinc potentiates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced dopamine depletion in caudate nucleus of mice brain
    Neuroscience Letters, vol. 335, no. 1, pp. 25–28, 2002
50. Effects of mercury vapor inhalation on reactive oxygen species and antioxidant enzymes in rat brain and kidney are minimal
    Journal of Applied Toxicology, vol. 22, no. 3, pp. 167–172, 2002
51. Acute Toxicity of Carbonyl Iron and Sodium Iron EDTA Compared with Ferrous Sulfate in Young Rats
    Regulatory Toxicology and Pharmacology, vol. 36, no. 3, pp. 280–286, 2002
52. Methamphetamine-induced alteration in striatal p53 and bcl-2 expressions in mice
    Molecular Brain Research, vol. 91, no. 1-2, pp. 174–178, 2001
53. Adolescent nicotine exposure produces immediate and long-term changes in CNS noradrenergic and dopaminergic function
    Brain Research, vol. 892, no. 2, pp. 269–280, 2001
54. Induction of the immediate early genes egr-1 and c-fos by methamphetamine in mouse brain
    Brain Research, vol. 919, no. 1, pp. 31–40, 2001
55. C-type natriuretic peptide (CNP) regulates cocaine-induced dopamine increase and immediate early gene expression in rat brain
    European Journal of Neuroscience, vol. 14, no. 10, pp. 1702–1708, 2001
56. Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase
    Journal of Neurochemistry, vol. 76, no. 3, pp. 745–749, 2001
57. Aging increases the susceptiblity to methamphetamine-induced dopaminergic neurotoxicity in rats: correlation with peroxynitrite production and hyperthermia
    Journal of Neurochemistry, vol. 78, no. 5, pp. 952–959, 2001
58. Chapter 5 Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine
    The Alkaloids: Chemistry and Biology, vol. 56, pp. 79–113, 2001
59. Chapter 7 Changes in gene expression and signal transduction following ibogaine treatment
    The Alkaloids: Chemistry and Biology, vol. 56, pp. 135–153, 2001
60. Chapter 10 Ibogaine neurotoxicity assessment: Electrophysiological, neurochemical, and neurohistological methods
    The Alkaloids: Chemistry and Biology, vol. 56, pp. 193–210, 2001
61. Neuroprotective role of ?-carnitine in the 3-nitropropionic acid induced neurotoxicity
    Toxicology Letters, vol. 125, no. 1-3, pp. 67–73, 2001
62. Effects of Manganese on Inositol Polyphosphate Receptors and Nitric Oxide Synthase Activity in Rat Brain
    International Journal of Toxicology, vol. 20, no. 5, pp. 275–280, 2001
63. Quinolinic acid induces oxidative stress in rat brain synaptosomes
    Neuroreport, vol. 12, no. 4, pp. 871–874, 2001
64. Oxidative Stress and Reactive Nitrogen Species Generation during Renal Ischemia
    Toxicological Sciences, vol. 63, no. 1, pp. 143–148, 2001
65. Preface: Recent advances of neurobiological basis of stimulant-induced sensitization
    Addiction Biology, vol. 5, no. 3, pp. 321–324, 2000
66. Role of peroxynitrite in methamphetamine-induced dopaminergic neurotoxicity and sensitization in mice
    Addiction Biology, vol. 5, no. 3, pp. 331–341, 2000
67. A Dose-Response Study of Ibogaine-Induced Neuropathology in the Rat Cerebellum
    Toxicological Sciences, vol. 57, no. 1, pp. 95–101, 2000
68. Comparative neurobiological effects of ibogaine and MK-801 in rats
    Drug and Alcohol Dependence, vol. 59, no. 2, pp. 143–151, 2000
69. Dopamine toxicity following long term exposure to low doses of 3-nitropropionic acid (3-NPA) in rats
    Toxicology Letters, vol. 116, no. 1-2, pp. 113–118, 2000
70. Exposure of mice to tobacco smoke attenuates the toxic effect of methamphetamine on dopamine systems
    Toxicology Letters, vol. 118, no. 1-2, pp. 43–46, 2000
71. Role of neuronal nitric oxide in methamphetamine neurotoxicity and protection by nNOS inhibitor
    Pure and Applied Chemistry, vol. 72, no. 6, pp. 1001–1006, 2000
72. Cellular determinants of reduced adaptability of the aging brain: neurotransmitter utilization and cell signaling responses after MDMA lesions
    Brain Research, vol. 879, no. 1-2, pp. 163–173, 2000
73. DNA damage in brain mitochondria caused by aging and MPTP treatment
    Brain Research, vol. 885, no. 1, pp. 45–52, 2000
74. Selenium, an antioxidant, attenuates methamphetamine-induced dopaminergic toxicity and peroxynitrite generation
    Brain Research, vol. 855, no. 1, pp. 186–191, 2000
75. Selenium, an antioxidant, protects against methamphetamine-induced dopaminergic neurotoxicity
    Brain Research, vol. 818, no. 2, pp. 575–578, 1999
76. Ibogaine blocked methamphetamine-induced hyperthermia and induction of heat shock protein in mice
    Brain Research, vol. 823, no. 1-2, pp. 213–216, 1999
77. Methamphetamine generates peroxynitrite and produces dopaminergic neurotoxicity in mice: protective effects of peroxynitrite decomposition catalyst
    Brain Research, vol. 837, no. 1-2, pp. 15–21, 1999
78. Effect of the Dopaminergic Neurotoxin MPTP on Cocaine-Induced Locomotor Sensitization
    Pharmacology Biochemistry and Behavior, vol. 63, no. 1, pp. 101–107, 1999
79. Acute ibogaine injection induces expression of the immediate early genes, egr-1 and c-fos, in mouse brain
    Molecular Brain Research, vol. 74, no. 1-2, pp. 237–241, 1999
80. Neuroprotective Role of Melatonin in Methamphetamine- and 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Dopaminergic Neurotoxicity
    Annals of the New York Academy of Sciences, vol. 890, no. 1 NEUROPROTECTI, pp. 119–119, 1999
81. Protective Effect of l-Carnitine in the Neurotoxicity Induced by the Mitochondrial Inhibitor 3-Nitropropionic Acid (3-NPA)
    Annals of the New York Academy of Sciences, vol. 890, no. 1 NEUROPROTECTI, pp. 173–178, 1999
82. Reduced levels of catalase activity potentiate MPP+-induced toxicity: comparison between MN9D cells and CHO cells
    Toxicology Letters, vol. 104, no. 1-2, pp. 49–56, 1999
83. Manganese scavenges superoxide and hydroxyl radicals: an in vitro study in rats
    Neuroscience Letters, vol. 261, no. 1-2, pp. 21–24, 1999
84. Effects of 7-Nitroindazole, an NOS Inhibitor on Methamphetamine-Induced Dopaminergic and Serotonergic Neurotoxicity in Micea
    Annals of the New York Academy of Sciences, vol. 844, no. 1 THE NEUROCHEM, pp. 122–130, 1998
85. The Impact of Gender and Estrogen on Striatal Dopaminergic Neurotoxicity
    Annals of the New York Academy of Sciences, vol. 844, no. 1 THE NEUROCHEM, pp. 153–165, 1998
86. Acute Effects of Dexfenfluramine (d-FEN) and Methylenedioxymethamphetamine (MDMA) before and after Short-Course, High-Dose Treatment
    Annals of the New York Academy of Sciences, vol. 844, no. 1 THE NEUROCHEM, pp. 183–190, 1998
87. Methamphetamine Treatment Affects Blood and Liver S-Adenosylmethionine (SAM) in Mice: Correlation with Dopamine Depletion in the Striatuma
    Annals of the New York Academy of Sciences, vol. 844, no. 1 THE NEUROCHEM, pp. 191–200, 1998
88. In Vivo Ibogaine Blockade and In Vitro PKC Action of Cocainea
    Annals of the New York Academy of Sciences, vol. 844, no. 1 THE NEUROCHEM, pp. 227–244, 1998
89. Effect of Ibogaine on the Various Sites of the NMDA Receptor Complex and Sigma Binding Sites in Rat Braina
    Annals of the New York Academy of Sciences, vol. 844, no. 1 THE NEUROCHEM, pp. 245–251, 1998
90. Neurochemical and Neuroendocrine Effects of Ibogaine in Rats: Comparison to MK-801
    Annals of the New York Academy of Sciences, vol. 844, no. 1 THE NEUROCHEM, pp. 252–264, 1998
91. Alteration in Electroencephalogram and Monoamine Concentrations in Rat Brain following Ibogaine Treatment
    Annals of the New York Academy of Sciences, vol. 844, no. 1 THE NEUROCHEM, pp. 265–273, 1998
92. Age-related susceptibility to 3,3'-iminodipropionitrile-induced olfactory mucosal damage
    Neurobiology of Aging, vol. 19, no. 6, pp. 569–574, 1998
93. Effect of acute exposure to 3-nitropropionic acid on activities of endogenous antioxidants in the rat brain
    Neuroscience Letters, vol. 251, no. 3, pp. 173–176, 1998
94. Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization
    Neuropharmacology, vol. 37, no. 6, pp. 781–791, 1998
95. Gestational exposure to cocaine or pharmacologically related compounds: Effects on behavior and striatal dopamine receptors
    Life Sciences, vol. 63, no. 22, pp. 2015–2022, 1998
96. Resistance of neuronal nitric oxide synthase-deficient mice to cocaine-induced locomotor sensitization
    Psychopharmacology, vol. 140, no. 3, pp. 378–386, 1998
97. The effects of chronic exposure of manganese on antioxidant enzymes in different regions of rat brain
    Neuroscience Research Communications, vol. 21, no. 2, pp. 135–144, 1997
98. Frequency of spontaneous and induced micronuclei in the peripheral blood of aging mice
    Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol. 381, no. 1, pp. 105–110, 1997
99. Systemic administration of MPTP induces thalamic neuronal degeneration in mice
    Brain Research, vol. 759, no. 1, pp. 9–17, 1997
100. Methamphetamine-induced hyperthermia in mice: examination of dopamine depletion and heat-shock protein induction
     Brain Research, vol. 771, no. 2, pp. 221–227, 1997
101. Measuring S-adenosylmethionine in whole blood, red blood cells and cultured cells using a fast preparation method and high-performance liquid chromatography
     Journal of Chromatography B: Biomedical Sciences and Applications, vol. 696, no. 1, pp. 145–152, 1997
102. Gestational retinoic acid exposure: A sensitive period for effects on neonatal mortality and cerebellar development
     Neurotoxicology and Teratology, vol. 19, no. 5, pp. 335–346, 1997
103. Role of Heat Shock Proteins in MPTP-Induced Neurotoxicity
     Annals of the New York Academy of Sciences, vol. 825, no. 1 Neuroprotecti, pp. 167–178, 1997
104. Nitric Oxide Is a Mediator of Methamphetamine (METH)-Induced Neurotoxicity.
     Annals of the New York Academy of Sciences, vol. 801, no. 1 Cellular and , pp. 174–186, 1996
105. Me thamphe tarnine-Induced Dopaminergic Toxicity in Mice.
     Annals of the New York Academy of Sciences, vol. 801, no. 1 Cellular and , pp. 187–198, 1996
106. Ibogaine Produces Neurodegeneration in Rat, but Not Mouse, Cerebellum.
     Annals of the New York Academy of Sciences, vol. 801, no. 1 Cellular and , pp. 217–226, 1996
107. NOS and fos in Rat and Mouse Brain Regions.
     Annals of the New York Academy of Sciences, vol. 801, no. 1 Cellular and , pp. 227–238, 1996
108. Alterations in Electroencephalographic Signals and Monoamine Concentrations in the Rat Brain Following Cocaine and Methamphetamine Treatment
     Annals of the New York Academy of Sciences, vol. 801, no. 1 Cellular and , pp. 394–400, 1996
109. MPP-induced neurotoxicity in mouse is age-dependent: evidenced by the selective inhibition of complexes of electron transport
     Brain Research, vol. 715, no. 1-2, pp. 1–8, 1996
110. The dopamine-depleting effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in CD-1 mice are gender-dependent
     Brain Research, vol. 735, no. 2, pp. 232–238, 1996
111. Heat shock proteins protect cultured fibroblasts from the cytotoxic effects of MPP+
     Brain Research, vol. 735, no. 1, pp. 42–49, 1996
112. Neuroendocrine and neurochemical effects of acute ibogaine administration: a time course evaluation
     Brain Research, vol. 737, no. 1-2, pp. 215–220, 1996
113. Effects of ibogaine, and cocaine and morphine after ibogaine, on ventral tegmental dopamine neurons
     Life Sciences, vol. 59, no. 12, pp. PL199–PL205, 1996
114. Neonatal MSG reduces hypothalamic DA, ß-endorphin, and delays weight gain in genetically obese (Aviable yellow/a) mice
     Pharmacology Biochemistry and Behavior, vol. 53, no. 2, pp. 425–432, 1996
115. ROLE OF METALLOTHIONEIN AND OTHER ANTIOXIDANTS IN SCAVENGING SUPEROXIDE RADICALS AND THEIR POSSIBLE ROLE IN NEUROPROTECTION
     Neurochemistry International, vol. 29, no. 2, pp. 145–152, 1996
116. Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine (MDMA) treatment in rhesus monkeys
     Neurotoxicology and Teratology, vol. 17, no. 5, pp. 531–543, 1995
117. Manganese-induced reactive oxygen species: Comparison between Mn+2 and Mn+3
     Neurodegeneration, vol. 4, no. 3, pp. 329–334, 1995
118. MPTP- and MPP+-induced effects on body temperature exhibit age- and strain-dependence in mice
     Brain Research, vol. 688, no. 1-2, pp. 161–170, 1995
119. Low Environmental Temperatures or Pharmacologic Agents That Produce Hypothermia Decrease Methamphetamine Neurotoxicity in Mice
     Annals of the New York Academy of Sciences, vol. 765, no. 1 Neuroprotecti, pp. 338–338, 1995
120. MPTP-induced oxidative stress and neurotoxicity are age-dependent: Evidence from measures of reactive oxygen species and striatal dopamine levels
     Synapse, vol. 18, no. 1, pp. 27–34, 1994
121. Phencyclidine and (+)-MK-801-induced circling preference: Correlation with monoamine levels in striatum of the rat brain
     Neurotoxicology and Teratology, vol. 16, no. 4, pp. 335–342, 1994
122. Postnatal methylazoxymethanol: Sensitive periods and regional selectivity of effects
     Neurotoxicology and Teratology, vol. 16, no. 6, pp. 631–637, 1994
123. Acute effects of perinatal hypoxic insult on concentrations of dopamine, serotonin, and metabolites in fetal monkey brain
     International Journal of Developmental Neuroscience, vol. 12, no. 2, pp. 127–131, 1994
124. Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produces selective serotonergic depletion in the nonhuman primate
     Neurotoxicology and Teratology, vol. 15, no. 2, pp. 91–96, 1993
125. Development of dopamine and ? systems in rat brain: the effect of prenatal phencyclidine exposure
     Developmental Brain Research, vol. 73, no. 1, pp. 25–33, 1993
126. Iron/ascorbate-induced lipid peroxidation changes membrane fluidity and muscarinic cholinergic receptor binding in rat frontal cortex
     Neurochemistry International, vol. 23, no. 5, pp. 479–484, 1993
127. Prenatal haloperidol exposure: Effects on brain weights and caudate neurotransmitter levels in rats
     Brain Research Bulletin, vol. 29, no. 3-4, pp. 449–458, 1992
128. Age and Dietary Factors in Hippocampal Sensitivity to Trimethyltin
     Annals of the New York Academy of Sciences, vol. 648, no. 1 Neurotoxins a, pp. 340–342, 1992
129. Ontogeny of the enhanced behavioral response to amphetamine in amphetamine-pretreated rats
     Psychopharmacology, vol. 100, no. 3, pp. 377–382, 1990
130. Altered hepatic microsomal function and elevated protooncogene expression as residual effects in rats exposed to delta-9-tetrahydrocannabinol
     Biochemical and Biophysical Research Communications, vol. 160, no. 1, pp. 217–221, 1989
131. Acute effects of marijuana smoke on complex operant behavior in rhesus monkeys
     Life Sciences, vol. 45, no. 6, pp. 465–475, 1989
132. Adrenocortical, ß-endorphin and behavioral responses to graded stressors in differentially reared rats
     Physiology & Behavior, vol. 42, no. 2, pp. 125–130, 1988
133. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA)*1
     Toxicology and Applied Pharmacology, vol. 94, no. 3, pp. 448–457, 1988
134. Determination of amino acids in different regions of the rat brain application to the acute effects of tetrahydrocannabinol (THC) and trimethyltin (TMT)
     Life Sciences, vol. 42, no. 20, pp. 2029–2035, 1988
135. Gestational exposure to phencyclidine (PCP) in rats decreases PCP binding sites in term fetal brain
     International Journal of Developmental Neuroscience, vol. 6, no. 6, pp. 547–552, 1988
136. The Effect of Isolation Rearing and Stress on Monoamines in Forebrain Nigrostriatal, Mesolimbic, and Mesocortical Dopamine Systems
     Annals of the New York Academy of Sciences, vol. 537, no. 1 The Mesocorti, pp. 512–514, 1988
137. Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC)
     Brain Research, vol. 436, no. 1, pp. 193–198, 1987
138. Effects of chronic delta-9-THC treatment on cardiac beta-adrenoceptors in rats
     Pharmacology Biochemistry and Behavior, vol. 28, no. 2, pp. 171–174, 1987
139. Effect of trimethyltin on ornithine decarboxylase in various regions of the mouse brain
     Toxicology Letters, vol. 36, no. 1, pp. 67–72, 1987
140. Prenatal reserpine exposure in rats decreases caudate nucleus dop amine receptor binding in female offspring
     Toxicology Letters, vol. 31, no. 3, pp. 195–201, 1986